Health In Tech reaffirms FY2026 sales guidance of $45M-$50M
Health In Tech (NASDAQ: HIT) affirms its FY2026 sales outlook at $45.000M-$50.000M, unchanged from prior guidance and versus a $46.813M estimate.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.